First generic companies move towards advanced overseas market for better conditions

The advancement of domestic export-oriented, first-generic pharmaceutical companies into advanced countries such as U.S. and Europe is gaining momentum via a series of export stimulus measures, in a bid to overcome more intensified assaults by India and China in the Asian and South American markets, according to industry sources recently.

These first generic companies are again mapping out t...